# Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus

> **NCT01389895** · PHASE1 · TERMINATED · sponsor: **Amgen** · enrollment: 1 (actual)

## Conditions studied

- Cutaneous Lupus
- Lupus

## Interventions

- **DRUG:** AMG 557
- **DRUG:** AMG 557 Placebo

## Key facts

- **NCT ID:** NCT01389895
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** slow enrollment
- **Last updated:** 2014-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01389895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01389895, "Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01389895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*